You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

2d college gets meningitis vaccine

GENEVA — The Swiss drug maker Novartis said a second US university is using its new vaccine against meningitis B. The vaccine, Bexsero, is being used at the University of California Santa Barbara until March 7 to help protect 20,000 students and staff after an outbreak.

The vaccine shot for the B strain of the meningitis bacteria is approved for use in Europe, Australia, and Canada, but not yet for general use in the United States.

Continue reading below

But the Food and Drug Administration has approved the use of Bexsero twice in response to outbreaks at college campuses. It is the first vaccine against the B strain of meningitis.

Princeton University said that almost 5,300 people got the vaccine last year in an effort to halt an outbreak there.

Loading comments...

Wake up with today's top stories.

Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
or
Please enter a valid email
BostonGlobe.com will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com